113 related articles for article (PubMed ID: 33085544)
1. Analysis of
Zhao H; Chen C; Chen X; Zhang D; Li J; Yang C; Ren C; Ren X; Fu X; Li Y; He J; Zhao H
DNA Cell Biol; 2020 Oct; ():. PubMed ID: 33085544
[TBL] [Abstract][Full Text] [Related]
2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
3. The human CNOT1-CNOT10-CNOT11 complex forms a structural platform for protein-protein interactions.
Mauxion F; Basquin J; Ozgur S; Rame M; Albrecht J; Schäfer I; Séraphin B; Conti E
Cell Rep; 2023 Jan; 42(1):111902. PubMed ID: 36586408
[TBL] [Abstract][Full Text] [Related]
4. C2ORF29/CNOT11 and CNOT10 form a new module of the CCR4-NOT complex.
Mauxion F; Prève B; Séraphin B
RNA Biol; 2013 Feb; 10(2):267-76. PubMed ID: 23232451
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
Zhang L; Luo B; Dang YW; He RQ; Peng ZG; Chen G; Feng ZB
J Cancer; 2019; 10(22):5355-5370. PubMed ID: 31632480
[No Abstract] [Full Text] [Related]
6. Integrated analysis of long noncoding RNA expression profiles in lymph node metastasis of hepatocellular carcinoma.
Ma J; Zhang L; Yang P; Zeng ZC; Xiang ZL
Gene; 2018 Nov; 676():47-55. PubMed ID: 29981417
[TBL] [Abstract][Full Text] [Related]
7. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
10. Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study.
Huang WT; Wang HL; Yang H; Ren FH; Luo YH; Huang CQ; Liang YY; Liang HW; Chen G; Dang YW
Onco Targets Ther; 2016; 9():5163-80. PubMed ID: 27578984
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
[TBL] [Abstract][Full Text] [Related]
12. ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma.
Zhang Y; Pang S; Sun B; Zhang M; Jiao X; Lai L; Qian Y; Yang N; Yang W
Front Oncol; 2022; 12():884066. PubMed ID: 35912257
[TBL] [Abstract][Full Text] [Related]
13. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
14. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
PeerJ; 2021; 9():e11342. PubMed ID: 33987018
[TBL] [Abstract][Full Text] [Related]
15. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
16. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
Front Oncol; 2022; 12():953529. PubMed ID: 36059705
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics analysis of pyroptosis regulation patterns and characterization of tumor microenvironment in patients with hepatocellular carcinoma.
Shang B; Wang R; Qiao H; Zhao X; Wang L; Sui S
PeerJ; 2023; 11():e15340. PubMed ID: 37193028
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
20. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
